West Pharmaceutical rises after lifting 2026 profit forecast

West Pharmaceutical Services

23/04/2026 12:46

** Shares of medical equipment maker West Pharmaceutical WST.N rise 18.44% to $325 premarket

** Co raises FY 2026 adjusted EPS forecast to $8.40 to $8.75 per share, up from its prior forecast of $7.85 to $8.20 per share

** Analysts on average were expecting $8.01 per share - LSEG data

** Posts Q1 adjusted profit of $2.13 per share, above analysts' estimate of $1.68 per share

** "We see the 1Q results as a sticker shock positive update, with organic growth of >15% and EPS ~26% above," Evercore ISI says

** As of last close, WST shares down 0.3% YTD

 (Reporting by Kunal Das in Bengaluru)

 ((Kunal.Das2@thomsonreuters.com;))